5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

M.K. Sutherland, C.P. Yu, M. Anderson, W.P. Zeng, N. van Rooijen, E.L. Sievers, I.S. Grewal, C.L. Law

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)440-448
JournalMABS
Volume2
Issue number4
DOIs
Publication statusPublished - 2010

Cite this

Sutherland, M. K., Yu, C. P., Anderson, M., Zeng, W. P., van Rooijen, N., Sievers, E. L., ... Law, C. L. (2010). 5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. MABS, 2(4), 440-448. https://doi.org/10.4161/mabs.12203